Practice experience with topical calcineurin inhibitors;Klinische erfahrungen mit topischen calcineurin-inhibitoren in der Praxis

Hautarzt

Volumn 54, Issue 5, 2003, Pages 432-439

  Lubbe J ^a  

^a GENEVA UNIVERSITY HOSPITALS   (Switzerland)

Author keywords

Atopic Eczema; Pimecrolimus; Review; Tacrolimus; Topical calcineurin inhibitors

Indexed keywords

CALCINEURIN INHIBITOR; CYCLOSPORIN; HYDROCORTISONE; PIMECROLIMUS; TACROLIMUS; CALCINEURIN; DRUG DERIVATIVE; IMMUNOSUPPRESSIVE AGENT;

ALCOHOL INTOLERANCE; ARTICLE; ATOPIC DERMATITIS; BACTERIAL COLONIZATION; CLINICAL TRIAL; DRUG ABSORPTION; GENODERMATOSIS; HERPES SIMPLEX; HUMAN; NETHERTON DISEASE; SIDE EFFECT; SKIN BURNING SENSATION; SKIN INFECTION; STAPHYLOCOCCUS AUREUS; CONTROLLED CLINICAL TRIAL; DRUG ANTAGONISM; IMMUNOLOGY; RANDOMIZED CONTROLLED TRIAL; REVIEW; SKIN ABSORPTION; TOPICAL DRUG ADMINISTRATION;

ADMINISTRATION, TOPICAL; CALCINEURIN; DERMATITIS, ATOPIC; HUMANS; IMMUNOSUPPRESSIVE AGENTS; RANDOMIZED CONTROLLED TRIALS; SKIN ABSORPTION; TACROLIMUS;

EID: 0037495273     PISSN: 00178470     EISSN: None     Source Type: Journal    
DOI: 10.1007/s00105-003-0527-0     Document Type: Article

References (51)

1. Lauerma AI, Maibach H, Granlund H et al. (1992) Inhibition of contact allergy reactions by topical FK-506. Lancet 340:556
2. Nagakawa H, Etoh T, Ishibashi Y et al. (1994) Tacrolimus ointment for atopic dermatitis. Lancet 344:883
3. Aoyama H, Tabata N, Tanaka M et al. (1995) Successful treatment of resistant facial lesions of atopic dermatitis with 0.1% FK-506 ointment. Br J Dermatol 133:494-496
4. Van Leent E, Gräber M, Thurston M et al. (1998) Effectiveness of the ascomycin macrolactam SDZ A5M 981 in the topical treatment of atopic dermatitis. Arch Dermatol 134:805-809
5. Van Leent E, Ebelin ME, Burtin P et al. (2002) Low systemic exposure after repeated application of pimecrolimus (Elidel®, SDZ ASM 981) in patients with atopic dermatitis. Dermatology 204:63-68
6. Harper J, Lakhanpaul M, Wahn U (2001) Pimecrolimus (Elidel, 5DZ ASM 981 cream 1%) blood levels are consistently low in children with extensive atopic eczema. J Eur Acad Dermatol Venereol 15 [Suppl 2]:S109
7. Reitamo S (2002) Topical macrolide immunomodulators for therapy of atopic dermatitis. In: Bieber T, Leung D (eds) Atopic dermatitis. Marcel Dekker, New York
8. Kawashima M, Nagakawa H, Ohtsuki M et al. (1996) Tacrolimus concentrations in blood during topical treatment of atopic dermatitis. Lancet 348:1240-1241
9. Ruzicka T, Assmann T, Homey B (1999) Tacrolimus - the drug for the turn of the century? Arch Dermatol 135:574-580
10. Bekersky I, Fitzsimmons W, Tanase A et al. (2001) Nonclinical and early clinical development of tacrolimus ointment for the treatment of atopic dermatitis. J Am Acad Dermatol 44:S17-27
11. Allen A, Siegfried E, Silverman R et al. (2001) Significant absorption of topical tacrolimus in 3 patients with Netherton syndrome. Arch Dermatol 137:747-750
12. Suga Y, Tsubai R, Hashimoto Y et al. (2000) A case of ichthyosis linearis circumflexa successfully treated with topical tacrolimus. J Am Acad Dermatol 42:520-522
13. Ruzicka T, Bieber T, Schöpf, E et al. (1997) A short-term trial of tacrolimus ointment for atopic dermatitis. N Engl J Med 337:816-821
14. Boguniewicz M, Fiedler V, Raimer S et al. (1998) A randomized, vehicle-controlled trial of tacrolimus ointment for treatment of atopic dermatitis in children. J Allergy Clin Immunol 102:637-644
15. Paller A, Eichenfield L, Leung D et al. (2001) A 12-week study of tacrolimus ointment for the treatment of atopic dermatitis in pediatric patients. J Am Acad Dermatol 44 [Suppl]:s47-s57
16. Kang S, Lucky A, Pariser D et al. (2001) Long-term safety and efficacy of tacrolimus ointment for the treatment of atopic dermatitis in children. J Am Acad Dermatol 44 [Suppl]:s58-s64
17. Reitamo S, Wollenberg A, Schöpf E et al. (2000) Safety and efficacy of 1 year of tacrolimus ointment monotherapy in adults with atopic dermatitis. Arch Dermatol 136:999-1006
18. Soter N, Fleischer A, Webster G et al. (2001) Tacrolimus ointment for the treatment of atopic dermatitis in adult patients: part II, safety. J Am Acad Dermatol 44 [Suppl]:s39-s46
19. Alaiti S, Kang S, Fiedler V et al. (1998) Tacrolimus (FKS06) ointment for atopic dermatitis: a phase I study in adults and children. J Am Acad Dermatol 38:69-76
20. Eichenfield L, Lucky A, Boguniewicz M et al. (2002) Safety and efficacy of pimecrolimus (ASM 981) cream 1% in the treatment of mild and moderate atopic dermatitis in children and adolescents. J Am Acad Dermatol 46:495-504
21. Lübbe J, Pournaras CC, Saurat JH (2000) Eczema herpeticum during treatment of atopic dermatitis with 0.1% tacrolimus ointment. Dermatology 201:249-251
22. Wahn U, Bos J, Goodfield M et al. (2002) Efficacy and safety of pimecrolimus cream in the long-term management of atopic dermatitis in children. Pediatrics 110:1-8
23. Lübbe J (2001) Topical tacrolimus for atopic dermatitis: euphoria and vigilance. Dermatology 203:1-2
24. Tschanz C, Lübbe J (2001) Effets secondaires du traitement de la dermite atopique par tacrolimus topique (FKS06): l'expérience genevoise. Med Hyg 59:1011-1013
25. Lübbe J, Sanchez-Politta S, Tschanz C, Saurat J-H (in press) Adults with atopic dermatitis, herpes simplex, and topical therapy with Tacrolismus; what kind of prevention? Arch Dermatol
26. Bork K, Bräuninger W (1988) Increasing incidence of eczema herpeticum: analysis of seventy-five cases. J Am Acad Dermatol 19:1024-1029
27. Kino T, Hatanaka H, Hashimoto M et al. (1987) FK-S06, a novel immunosuppressant isolated from a streptomyces. J Antibiot XL:1249-1255
28. Pournaras CC, Lübbe J, Saurat JH (2001) Staphylococcal colonization in atopic dermatitis treatment with topical tacrolimus (FkS06). J Invest Dermatol 116:480-481
29. Cho SH, Strickland I, Boguniewcz M, Leung D (2001) Fibronectin and fibrinogen contribute to the enhanced binding of staphylococcus aureus to atopic skin. J Allergy Clin Immunol 108:269-274
30. Cho SH, Strickland I, Tomkinson A et al. (2001) Preferential binding of staphylococcus aureus to skin sites of Th2-mediated inflammation in a murine model. J Invest Dermatol 116:658-663
31. Hauk P, Leung D (2001) Tacrolimus (FK506): new treatment approach in superantigen-associated diseases like atopic dermatitis? J Allergy Clin Immunol 107:2
32. Lübbe J, Tschanz C, Saurat JH (2000) Lokalbehandlung des atopischen Ekzems mit Tacxrolimussalbe: Übersicht und Erfahrungsbericht. Dermatologica Helvetica 8:16-21
33. Olivier V, Lacour JP, Mousnier A et al. (2002) Treatment of chronic erosive oral lichen planus with low concentrations of topical tacrolimus. Arch Dermatol 138:1335-1338
34. Rozycki T, Rogers R, Pittelkow M et al. (2002) Topical tacrolimus in the treatment of symptomatic oral lichen planus: a series of 13 patients. J Am Acad Dermatol 46:27-34
35. Vente C, Reich K, Rupprecht R, Neumann C (1999) Erosive mucosal lichen planus: response to topical treatment with tacrolimus. Br J Dermatol 140:338-342
36. Lener E, Brieva J, Schachter M et al. (2001) Successful treatment of erosive lichen planus with topical tacrolimus. Arch Dermatol 137:419-422
37. Kalikatsou F, Hodgson T, Lewsey J et al. (2002) Management of recalcitrant ulcerative oral lichen planus with topical tacrolimus. J Am Acad Dermatol 46:45-41
38. Casson D, Eltumi M, Walker-Smith J, Murch S (2000) Topical tacrolimus may be effective in the treatment of oral and perineal Crohn's disease. Gut 47:436-440
39. Richter-Hinz D, Schuppe HC, Homey B et al. (2000) Topical tacrolimus (FK-506) is effective in the treatment of pyoderma gangraenosum. J Am Acad Dermatol February, part 1:304
40. Brouard M, Prins C, Chavaz P et al. (2002) Erosive pustular dermatosis of the leg: report of three cases. Br J Dermatol 147:765-769
41. Goldman BD (2000) Herpes serology for dermatologists. Arch Dermatol 136:1158-1161
42. Dale S, Shaw J (2000) Eosinophlic pustular folliculitis. Lancet 356:1235
43. Thiers B (2000) Topical tacrolimus: treatment failure in a patient with alopecia areata. Arch Dermatol 136:124
44. Schnopp C, Remling R, Möhrenschlager M et al. (2002) Topical tacrolimus (FK506) and mometasone fuorate in treatment of dyshidrotic palmar eczema: a randomized, observer-blinded trial. J Am Acad Dermatol 46:73-77
45. Remitz A, Reitamo S, Erkko P et al. (1999) Tacrolimus improves psoriasis in a microplaque assay. Br J Dermatol 141:103-107
46. Sugiura H, Uehara M, Hoshino N, Yamaji A (2001) An open study of a lotion formulation to improve tolerance of tacrolimus in facial atopic dermatitis. Br J Dermatol 145:795-798
47. Russell R, Richardson N, Wilson D (2001) Systemic absorption with complications during topical tacrolimus treatment for orofacial Crohn disease. J Pediatr Gastroenterol Nutr 32:207-208
48. Reitamo S, Rustin M, Ruzicka T et al. (2002) Efficacy and safety of tacrolimus ointment compared with hydrocortisone butyrate ointment in adult patients with atopic dermatitis. J Allergy Clin Immunol 109:547-555
49. Reitamo S, Van Leent E, Ho V et al. (2002) Efficacy and safety of tacrolimus ointment compared with hydrocortisone acetate ointment in children with atopic dermatitis. J Allergy Clin Immunol 109:539-546
50. Luger T, Van Leent E, Graeber M et al. (2001) SDZ ASM 981: an emerging safe and effective treatment for atopic dermatitis. Br J Dermatol 144:788-794
51. Vecchietti G, Kerl K, Hügli A et al. (in press) Topical Tacrolimus (FK506) for relapsing erosive stomatitis in paraneoplasic pemphigus Br J Dermatol